Quantum BioPharma Ltd. (QNTM)
2.82
-0.12
(-4.08%)
USD |
NASDAQ |
Oct 12, 16:00
2.80
-0.02
(-0.71%)
After-Hours: 06:50
Quantum BioPharma Shareholders Equity (Quarterly) : 7.949M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.949M |
| March 31, 2026 | 0.5952M |
| December 31, 2025 | 6.924M |
| September 30, 2025 | 8.652M |
| June 30, 2025 | 3.764M |
| March 31, 2025 | 5.733M |
| December 31, 2024 | 11.48M |
| September 30, 2024 | 16.29M |
| June 30, 2024 | 10.96M |
| March 31, 2024 | 12.03M |
| December 31, 2023 | 13.24M |
| September 30, 2023 | 14.84M |
| June 30, 2023 | 15.55M |
| March 31, 2023 | 20.86M |
| December 31, 2022 | 30.54M |
| September 30, 2022 | 36.14M |
| June 30, 2022 | 42.58M |
| Date | Value |
|---|---|
| March 31, 2022 | 46.76M |
| December 31, 2021 | 54.13M |
| September 30, 2021 | 60.15M |
| June 30, 2021 | 58.28M |
| March 31, 2021 | 68.51M |
| December 31, 2020 | 36.31M |
| September 30, 2020 | 31.86M |
| June 30, 2020 | 33.64M |
| March 31, 2020 | 29.93M |
| December 31, 2019 | 36.28M |
| September 30, 2019 | 46.39M |
| June 30, 2019 | 51.23M |
| March 31, 2019 | 37.05M |
| December 31, 2018 | 37.36M |
| September 30, 2018 | 51.28M |
| June 30, 2018 | 39.90M |
| March 31, 2018 | 10.19M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Numinus Wellness, Inc. | -2.815M |
| Cocrystal Pharma, Inc. | 1.044M |
| Edesa Biotech, Inc. | 8.811M |
| CNBX Pharmaceuticals, Inc. | -2.660M |
| Invion Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.39M |
| Total Liabilities (Quarterly) | 8.298M |
| Debt to Equity Ratio | 0.1212 |
| Current Ratio | 1.200 |
| Net Debt Paydown Yield | 0.23% |